Foto del docente

Michele Cavo

Alma Mater Professor

Alma Mater Studiorum - Università di Bologna

Adjunct professor

Department of Medical and Surgical Sciences

Publications

Tura, Sante; Cavo, Michele; Zinzani, Pier Luigi; Broccoli, Alessandro; Argnani, Lisa; Fiacchini, Mauro, Corso di malattie del sangue e degli organi emolinfopoietici, in: Capitolo 9: Il metodo della ricerca clinica, Bologna, Società Editrice Esculapio srl, 2020, pp. 617 - 621 [Chapter or essay]

Tura, Sante; Cavo, Michele; Zinzani, Pier Luigi; Broccoli, Alessandro, Corso di malattie del sangue e degli organi emolinfopoietici, Bologna, Società Editrice Esculapio srl, 2020, pp. 631 . [Research monograph]

Weisel K.; Spencer A.; Lentzsch S.; Avet-Loiseau H.; Mark T.M.; Spicka I.; Masszi T.; Lauri B.; Levin M.-D.; Bosi A.; Hungria V.; Cavo M.; Lee J.-J.; Nooka A.; Quach H.; Munder M.; Lee C.; Barreto W.; Corradini P.; Min C.-K.; Chanan-Khan A.A.; Horvath N.; Capra M.; Beksac M.; Ovilla R.; Jo J.-C.; Shin H.-J.; Sonneveld P.; Casneuf T.; Deangelis N.; Amin H.; Ukropec J.; Kobos R.; Mateos M.-V., Daratumumab, bortezomib, and dexamethasone in relapsed or refractory multiple myeloma: Subgroup analysis of CASTOR based on cytogenetic risk, «JOURNAL OF HEMATOLOGY & ONCOLOGY», 2020, 13, Article number: 115 , pp. 1 - 11 [Scientific article]Open Access

Landgren, C Ola; Chari, Ajai; Cohen, Yael C; Spencer, Andrew; Voorhees, Peter; Estell, Jane A; Sandhu, Irwindeep; Jenner, Matthew W; Williams, Catherine; Cavo, Michele; van de Donk, Niels W C J; Beksac, Meral; Moreau, Philippe; Goldschmidt, Hartmut; Kuppens, Steven; Bandekar, Rajesh; Clemens, Pamela L; Neff, Tobias; Heuck, Christoph; Qi, Ming; Hofmeister, Craig C, Daratumumab monotherapy for patients with intermediate-risk or high-risk smoldering multiple myeloma: a randomized, open-label, multicenter, phase 2 study (CENTAURUS), «LEUKEMIA», 2020, 0, pp. 0 - 0 [Scientific article]Open Access

Hungria V.; Martinez-Banos D.M.; Mateos M.-V.; Dimopoulos M.A.; Cavo M.; Heeg B.; Garcia A.; Lam A.; Machnicki G.; He J.; Fernandez M., Daratumumab Plus Bortezomib, Melphalan, and Prednisone Versus Standard of Care in Latin America for Transplant-Ineligible Newly Diagnosed Multiple Myeloma: Propensity Score Matching Analysis, «ADVANCES IN THERAPY», 2020, 37, pp. 4996 - 5009 [Scientific article]Open Access

Mateos, Maria-Victoria; Spencer, Andrew; Nooka, Ajay K; Pour, Ludek; Weisel, Katja; Cavo, Michele; Laubach, Jacob P; Cook, Gordon; Iida, Shinsuke; Benboubker, Lotfi; Usmani, Saad Z; Yoon, Sung-Soo; Bahlis, Nizar J; Chiu, Christopher; Ukropec, Jon; Schecter, Jordan M; Qin, Xiang; O'Rourke, Lisa; Dimopoulos, Meletios A, Daratumumab-based regimens are highly effective and well tolerated in relapsed or refractory multiple myeloma regardless of patient age: subgroup analysis of the phase 3 CASTOR and POLLUX studies, «HAEMATOLOGICA», 2020, 105, pp. 468 - 477 [Scientific article]Open Access

Goldschmidt H.; Dimopoulos M.A.; Rajkumar S.V.; Weisel K.C.; Moreau P.; Chng W.-J.; Mikala G.; Cavo M.; Ramasamy K.; Suryanarayan K.; Teng Z.; Labotka R.; Mateos M.V., Deepening responses associated with improved progression-free survival with ixazomib versus placebo as posttransplant maintenance in multiple myeloma, «LEUKEMIA», 2020, 34, pp. 3019 - 3027 [Scientific article]Open Access

Salvestrini V.; Ciciarello M.; Pensato V.; Simonetti G.; Laginestra M.A.; Bruno S.; Pazzaglia M.; De Marchi E.; Forte D.; Orecchioni S.; Martinelli G.; Bertolini F.; Mendez-Ferrer S.; Adinolfi E.; Di Virgilio F.; Cavo M.; Curti A., Denatonium as a Bitter Taste Receptor Agonist Modifies Transcriptomic Profile and Functions of Acute Myeloid Leukemia Cells, «FRONTIERS IN ONCOLOGY», 2020, 10, Article number: 1225 , pp. 1 - 17 [Scientific article]Open Access

Bonifazi F.; Barbato F.; Ravaioli F.; Sessa M.; Defrancesco I.; Arpinati M.; Cavo M.; Colecchia A., Diagnosis and Treatment of VOD/SOS After Allogeneic Hematopoietic Stem Cell Transplantation, «FRONTIERS IN IMMUNOLOGY», 2020, 11, Article number: 489 , pp. 489 - 489 [Scientific article]Open Access

Forte D.; Fanelli F.; Mezzullo M.; Barone M.; Corradi G.; Auteri G.; Bartoletti D.; Martello M.; Ottaviani E.; Terragna C.; Curti A.; Pagotto U.; Palandri F.; Cavo M.; Catani L., Disease-specific derangement of circulating endocannabinoids and n-acylethanolamines in myeloproliferative neoplasms, «INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES», 2020, 21, Article number: 3399 , pp. 1 - 11 [Scientific article]Open Access

Casadei B.; Argnani L.; Morigi A.; Lolli G.; Broccoli A.; Pellegrini C.; Nanni L.; Stefoni V.; Coppola P.E.; Carella M.; Cavo M.; Zinzani P.L., Effectiveness of chemotherapy after anti-PD-1 blockade failure for relapsed and refractory Hodgkin lymphoma, «CANCER MEDICINE», 2020, 9, pp. 7830 - 7836 [Scientific article]Open Access

Gentilini M.; Casadei B.; Broccoli A.; Argnani L.; Cavo M.; Zinzani P.L., Elderly Non-GCB Diffuse Large B-Cell Lymphoma Patient Responding to Lenalidomide after Epicardial Relapse: A Case Report, «ACTA HAEMATOLOGICA», 2020, 143, pp. 594 - 597 [Scientific article]

Carella M.; Stefoni V.; Pellegrini C.; Argnani L.; Cavo M.; Zinzani P.L., Finalization of autologous stem cell transplant in complex and multirelapsed follicular lymphoma, «TUMORI», 2020, 106, pp. NP5 - NP8 [Scientific article]

Gabrielli, Giulia; Broccoli, Alessandro; Pellegrini, Cinzia; Argnani, Lisa; Cavo, Michele; Zinzani, Pier Luigi, Idelalisib as a Bridge to Allogeneic Transplantation in Relapsed/Refractory Lymphoma With Renal Cancer: A Case Report, «CLINICAL LYMPHOMA MYELOMA & LEUKEMIA», 2020, 20, pp. e15 - e17 [Scientific article]

M. Barone, M. Barone, F. Ricci, G. Auteri, G. Corradi, D. Forte, N. Vianelli, Pier luigi Tazzari, F. Francia, M. Candela, F. Palandri, M. Cavo, S. Turroni, L. Catani, IDENTIFICATION OF POLYCYTHEMIA VERA-SPECIFIC BIOMARKERS OF OUTCOME BY NOVEL MULTIDIMENSIONAL ANALYSIS APPROACHES, in: Haematologica Journal, Haematologica XVI Congress of the Italian Society of Experimental Hematology Napoli, Italy, October 15-17, 2020 ABSTRACT BOOK, 2020, pp. 70 - 70 (atti di: XVI Congress of the Italian Society of Experimental Hematology Napoli, Italy, October 15-17, 2020, posticipato nel 2021 a Milano, 24-27 ottobre 2021) [Contribution to conference proceedings]